Rankings
▼
Calendar
▼
QNTM Q2 2016 Earnings Report — Quantum BioPharma Ltd. Revenue & Financial Results | Market Cap Arena
Quantum BioPharma Ltd.
QNTM
Q2 2016 Earnings
Reported May 31, 2016
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q2 2016
Q1 2016
Q2 2015
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
$0
—
—
—
—
EPS (Diluted)
$-0.05
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$0
Selling & Marketing
$0
General & Administrative
$5.5K
SG&A Expenses
$5.5K
Other Expenses
$0
Operating Expenses
$5.5K
Cost & Expenses
$5.5K
OPERATING INCOME
$0
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
-$5.5K
INCOME BEFORE TAX
-$5.5K
Income Tax Expense
$0
Net Income from Continuing Ops
-$5.5K
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$5.5K
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$5.5K
D&A
$0
EBIT
-$5.5K
EBITDA
-$5.5K
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
← FY 2016
QNTM Overview
Q3 2016 →